FindTrial
Sign In

Study of Uterus Lining Changes and Hormone Receptors in Women with Abnormal Uterine Bleeding

To correlate the histopathological features with expression of estrogen and progesterone receptors in endometrium of patients of Abnormal uterine bleeding at tertiary care hospital - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/107833
Enrollment
45
Registered
2026-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Dr Sambarto Bhadra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Study will include all the patients presenting with abnormal uterine bleeding undergoing endometrial biopsy or hysterectomy received to the surgical Pathology section of Department of Pathology at AVBRH Hospital of tertiary care hospital.

Exclusion criteria

Exclusion criteria: Abnormal Uterine Bleeding with other than endometrial cause.

Design outcomes

Primary

MeasureTime frame
To predict the role of Estrogen ,Progesterone receptor for the management of patient of Abnormal Uterine BleedingTimepoint: 2 years—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Sunita Vagha

Datta Meghe Institute of Higher Education and Research

sunitavagha@gmail.com9860244638

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026